Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1987 Jan;46(1):85. doi: 10.1136/ard.46.1.85-a

IgA serum levels and disease activity in ankylosing spondylitis.

J J Calabro
PMCID: PMC1002065  PMID: 3813682

Full text

PDF

Page 85

85

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calabro J. J., Amante C. M. Indomethacin in ankylosing spondylitis. Arthritis Rheum. 1968 Feb;11(1):56–64. doi: 10.1002/art.1780110108. [DOI] [PubMed] [Google Scholar]
  2. Calabro J. J. Sustained-release indomethacin in the management of ankylosing spondylitis. Am J Med. 1985 Oct 25;79(4C):39–51. doi: 10.1016/0002-9343(85)90514-5. [DOI] [PubMed] [Google Scholar]
  3. Franssen M. J., van de Putte L. B., Gribnau F. W. IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis. 1985 Nov;44(11):766–771. doi: 10.1136/ard.44.11.766. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES